LC-MS/MS comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-01-11. Numbers and descriptions here follow the published literature rather than marketing material.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
Laboratory studies often administer SR9009 by injection because oral absorption appears poor in rodents. Reported pharmacokinetic properties include rapid metabolism and low systemic exposure after oral dosing. Human pharmacokinetic data are sparse, so absorption, distribution, metabolism, and excretion in people are not well defined. Some research explores related REV-ERB compounds with improved drug-like properties. Regulatory approval for any REV-ERB agonist as a human medicine has not been granted to date.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule nuclear receptor ligand |
| Appearance | Off-white to pale yellow solid | Typical for research-grade powder |
| Solubility class | Soluble in DMSO; low water solubility | Common stock solutions use organic solvent |
| Typical stock solvent | Dimethyl sulfoxide | Used for laboratory assays |
| Common analytical method | HPLC with UV or mass detection | Used for identity and purity checks |
SR9009 is supplied as a solid research chemical, often in milligram quantities. Laboratories typically weigh it in a controlled environment because fine powders can disperse. Stock solutions are commonly prepared in dimethyl sulfoxide and stored in small aliquots to reduce freeze-thaw cycles. Personal protective equipment and chemical fume hoods are standard when handling unknown or potent compounds. These practices address laboratory safety rather than human use.
Identity and purity of SR9009 samples are usually checked with chromatographic and spectrometric methods. High-performance liquid chromatography can separate the compound from related impurities, while mass spectrometry provides molecular mass confirmation. Nuclear magnetic resonance spectroscopy may be used for structural verification in research settings. No single method proves biological activity, and certificates of analysis should be reviewed alongside raw data. Independent testing is often needed because online products vary widely.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Founded in 2007 and located in Culpeper, Virginia in Northern Virginia, the National Audio-Visual Conservation Center is the Library of Congress's newest building. It was constructed out of a former Federal Reserve storage center and Cold War bunker. The campus is designed to act as a single site to store all of the library's movie, television, and sound collections. It is named in honor of David Woodley Packard, whose Packard Humanities Institute oversaw the design and construction of the facility. The centerpiece of the complex is a reproduction Art Deco movie theater that presents free movie screenings to the public on a semi-weekly basis.
== Other metalloenzymes == There are two types of carbon monoxide dehydrogenase: one contains iron and molybdenum, the other contains iron and nickel. Parallels and differences in catalytic strategies have been reviewed. Pb2+ (lead) can replace Ca2+ (calcium) as, for example, with calmodulin or Zn2+ (zinc) as with metallocarboxypeptidases. A new class of Heme oxygenase (HO)-like metalloenzymes class has been identified. Some other metalloenzymes are given in the following table, according to the metal involved.
In December 1966, the UN further iterated that these sanctions were mandatory, and member states were explicitly barred from purchasing Rhodesian export goods, namely tobacco, chromium, copper, asbestos, sugar, and beef. The British government, having already adopted extensive sanctions of its own, dispatched a Royal Navy squadron to monitor oil deliveries in the port of Beira in Mozambique, from which a strategic pipeline ran to Umtali in Rhodesia. The warships were to deter "by force, if necessary, vessels reasonably believed to be carrying oil destined for (Southern) Rhodesia". Some Western nations, such as Switzerland and West Germany, which were not UN member states, continued to conduct business openly with Rhodesia – the latter remained the Smith government's largest trading partner in Western Europe until 1973, when it was admitted to the UN. Japan remained the chief recipient of Rhodesian exports outside the African continent, and Iran also supplied oil to Rhodesia in violation of the embargo. Portugal served as a conduit for Rhodesian goods, which it exported through Mozambique with false certificates of origin. South Africa, too, refused to observe the UN sanctions. In 1971, the Byrd Amendment was passed in the United States, permitting American firms to go on importing Rhodesian chromium and nickel products as normal. Despite the poor showing of sanctions, Rhodesia found it nearly impossible to obtain diplomatic recognition abroad. In 1970, the United States declared it would not recognise UDI "under [any] circumstances".
== Management == There is no cure for RA, but treatments can improve symptoms and slow the progression of the disease. Disease-modifying treatment has the best results when it is started early and aggressively. The results of a recent systematic review found that combination therapy with tumor necrosis factor (TNF) and non-TNF biologics plus methotrexate (MTX) resulted in improved disease control, Disease Activity Score (DAS)-defined remission, and functional capacity compared with a single treatment of either methotrexate or a biologic alone. The goals of treatment are to minimize symptoms such as pain and swelling, to prevent bone deformity (for example, bone erosions visible in X-rays), and to maintain day-to-day functioning. This is primarily addressed with disease-modifying antirheumatic drugs (DMARDs); dosed physical activity; analgesics and physical therapy may be used to help manage pain. RA should generally be treated with at least one specific anti-rheumatic medication while combination therapies and corticosteroids are common in treatment. The use of benzodiazepines (such as diazepam) to treat the pain is not recommended as it does not appear to help and is associated with risks.
Sources: en.wikipedia.org
== Urogenital diaphragm (perineal membrane) == The urogenital diaphragm, or perineal membrane, is present over the anterior pelvic outlet below the pelvic diaphragm. The exact structure description is controversial. Despite the controversy, MRI imaging studies support the existence of the structure. Superficial and inferior muscles of the perineum (urogenital diaphragm):
Myostatin inhibitors are a class of drugs that work by blocking the effect of myostatin, which inhibits muscle growth. In animal models and limited human studies, myostatin inhibitors have increased muscle size. They are being developed to treat obesity, sarcopenia, muscular dystrophy, and other illnesses.
==== Amputations ==== Save the Children reported 10 children a day in Gaza had lost their limbs, which would result in a lifetime of medical needs. A UNICEF spokesperson James Elder was quoted after returning from Gaza in mid-December 2023, that around 1,000 children had lost one or both legs since the 7 October attacks and the start of the war. According to the British doctor Ghassan Abu-Sittah, "This is the biggest cohort of pediatric amputees in history". In mid-December 2023, a teenager's amputation performed without anesthesia on her families kitchen table by her uncle who is a doctor went viral on social media. She and a sibling had climbed to the top of the building to call their father who is overseas before the building was reportedly struck by IDF tank fire, and she was rushed inside to her uncle. In early-January 2024, an 11-year-old speaking to reporters about her injuries which included an amputated leg and with the other severely injured expressed her hope in getting an artificial limb, and lamented how her life has become "ugly and sad" after the injury. Other children's stumps after amputation had to be re-opened after infections had set in. By June 2024, doctors in Gaza estimated as many as 3,000 children had lost limbs since October 2023. A WHO Emergency Medical Team coordinator also cautioned that due to lack of medical expertise and time, some of the amputations done were unnecessary or due to a time delay. The head of Humanity & Inclusion stated child amputees needed "immediate support" for prosthetics but that wasn't happening.
Sources: en.wikipedia.org
A typical Indian meal is built on a plain cereal, complemented by savoury dishes. The cooked cereal could be steamed rice; chapati, a thin unleavened bread; idli, a steamed breakfast cake; or dosa, a griddled pancake. The savoury dishes might include lentils, pulses, vegetables, meat, poultry and fish commonly spiced with ginger and garlic, but also coriander, cumin, turmeric, cinnamon, cardamom and others. In some instances, the ingredients may be mixed during the cooking process. India has distinctive vegetarian cuisines, each a feature of the geographical and cultural histories of its communities. About 20% to 39% of India's population consists of vegetarians. Although meat is eaten widely, the proportional consumption of meat is low. The most significant import of cooking techniques into India during the last millennium occurred during the Mughal Empire, spreading into northern India from regions to its northwest, along with dishes such as pilaf. Onions, garlic, almonds, and spices were added to the simple yogurt marinade of Persia. Rice was partially cooked and layered alternately with sauteed meat, the pot sealed tightly, and slow cooked according to another Persian cooking technique, to produce biryani, a feature of festive dining in many parts of India. The diversity of Indian food served worldwide has been partially concealed by the dominance of Punjabi cuisine.
=== Detection of phytopathogens === The agricultural industry is constantly striving to produce plant propagules or seedlings that are free of pathogens in order to prevent economic losses and safeguard health. Systems have been developed that allow detection of small amounts of the DNA of Phytophthora ramorum, an oomycete that kills oaks and other species, mixed in with the DNA of the host plant. Discrimination between the DNA of the pathogen and the plant is based on the amplification of ITS sequences, spacers located in ribosomal RNA gene's coding area, which are characteristic for each taxon. Field-based versions of this technique have also been developed for identifying the same pathogen.
== Further reading == Bud, Robert. "Biotechnology in the Twentieth Century." Social Studies of Science 21.3 (1991), 415–457 doi:10.1177/030631291021003002. Bud, Robert (1989). "History of 'biotechnology". Nature. 337 (6202): 10. Bibcode:1989Natur.337...10B. doi:10.1038/337010a0. PMID 2909886. S2CID 4354445. Dronamraju, Krishna R. Biological and Social Issues in Biotechnology Sharing. Brookfield: Ashgate Publishing Company, 1998. ISBN 9781840148978. Feldbaum, Carl (2002). "Some History Should Be Repeated". Science. 295 (5557): 975. doi:10.1126/science.1069614. PMID 11834802. S2CID 32595222. Rasmussen, Nicolas, Gene Jockeys: Life Science and the rise of Biotech Enterprise, Johns Hopkins University Press, (Baltimore), 2014. ISBN 978-1-42141-340-2.
15-Oxo-ETE). Other eicosanoid oxoreductases that use NAD+ and NADH as co-factors include: 12-hydroxyicosatetraenoate dehydrogenase which metabolizes 12-hydroxyeicosatetraenoic acid (12-HETE) and LTB4 to their corresponding 12-oxo analogs and 11-hydroxy-TXB2 dehydrogenase, which metabolizes TXB2 to its 11-oxo analog; and 15-hydroxyprostaglandin dehydrogenase (NAD+) which metabolizes (5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate to its 15-oxo analog. Other eicosanoid oxireductases that use NADP+ and NADPH as cofactors include LTB4 12-hydroxy dehydrogenase which metabolizes LTB4 to its 12-oxo analog, and 15-hydroxyprostaglandin-D dehydrogenase (NADP+), 15-hydroxyprostaglandin-I dehydrogenase (NADP+), and 15-hydroxyprostaglandin dehydrogenase (NADP+) which metabolize PGD2, PGI2, and (13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate, respectively, to their corresponding 15-oxo analogs.
Sources: en.wikipedia.org
SR9009 is a synthetic research compound that acts on REV-ERB nuclear receptors. It is not approved for human use and is sold only as a research chemical. Its effects have been studied mainly in cells and rodents.
It binds REV-ERB alpha and REV-ERB beta and changes the expression of genes tied to metabolism and circadian rhythm. These changes can affect mitochondria and energy use in animal models. The exact chain from receptor binding to physiological outcome is still being mapped.
No reliable human trials show that SR9009 improves athletic performance. Some rodent studies report endurance changes, but these results are not proof of human benefit. Its use in sport is prohibited, and quality and safety data are lacking.
SR9009 is a synthetic research compound that activates the REV-ERBα and REV-ERBβ nuclear receptors. It is not an approved drug and has no established human therapeutic use. Most published biological data come from cell and rodent studies.